| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
Etaracizumab manufacturers
- Etaracizumab
-
- $753.00
-
2026-07-27
- CAS:892553-42-3
- Purity: 99.32% (SEC-HPLC)
- Supply Ability: 10g
|
| | Etaracizumab Basic information |
| Product Name: | Etaracizumab | | Synonyms: | etaracizumab;Abegrin;Vitaxin;Research Grade Etaracizumab (DHC21902);Research Grade Etaracizumab | | CAS: | 892553-42-3 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Etaracizumab Structure]() |
| | Etaracizumab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Etaracizumab Usage And Synthesis |
| Uses | Etaracizumab (LM 609) is an αvβ3 integrin IgG1 monoclonal antibody. Etaracizumab inhibits angiogenesis and melanoma tumor growth. Etaracizumab can be used to research anticancer[1]. | | References | [1] Hersey P, et al. A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), + or - dacarbazine in patients with stage IV metastatic melanoma. Cancer. 2010 Mar 15;116(6):1526-34. DOI:10.1002/cncr.24821 |
| | Etaracizumab Preparation Products And Raw materials |
|